Authors:
ELSADR WM
PERLMAN DC
MATTS JP
NELSON ET
COHN DL
SALOMON N
OLIBRICE M
MEDARD F
CHIRGWIN KD
MILDVAN D
JONES BE
TELZAK EE
KLEIN O
HEIFETS L
HAFNER R
Citation: Wm. Elsadr et al., EVALUATION OF AN INTENSIVE INTERMITTENT-INDUCTION REGIMEN AND DURATION OF SHORT-COURSE TREATMENT FOR HUMAN IMMUNODEFICIENCY VIRUS-RELATED PULMONARY TUBERCULOSIS, Clinical infectious diseases, 26(5), 1998, pp. 1148-1158
Authors:
PAONE D
PERLMAN DC
PERKINS MP
KOCHEMS LM
SALOMON N
DESJARLAIS DC
Citation: D. Paone et al., ORGANIZATIONAL ISSUES IN CONDUCTING TUBERCULOSIS SCREENING AT A SYRINGE EXCHANGE PROGRAM, Journal of substance abuse treatment, 15(3), 1998, pp. 229-234
Authors:
PERLMAN DC
ELSADR WM
NELSON ET
MATTS JP
TELZAK EE
SALOMON N
CHIRGWIN K
HAFNER R
Citation: Dc. Perlman et al., VARIATION OF CHEST RADIOGRAPHIC PATTERNS IN PULMONARY TUBERCULOSIS BYDEGREE OF HUMAN IMMUNODEFICIENCY VIRUS-RELATED IMMUNOSUPPRESSION, Clinical infectious diseases, 25(2), 1997, pp. 242-246
Authors:
SALOMON N
PERLMAN DC
RUBENSTEIN A
MANDELMAN D
MCKINLEY FW
YANCOVITZ SR
Citation: N. Salomon et al., IMPLEMENTATION OF UNIVERSAL DIRECTLY OBSERVED THERAPY AT A NEW-YORK-CITY HOSPITAL AND EVALUATION OF AN OUTPATIENT DIRECTLY OBSERVED THERAPYPROGRAM, The international journal of tuberculosis and lung disease, 1(5), 1997, pp. 397-404
Authors:
PERLMAN DC
ELSADR WM
HEIFETS LB
NELSON ET
MATTS JP
CHIRGWIN K
SALOMON N
TELZAK EE
KLEIN O
KREISWIRTH BN
MUSSER JM
HAFNER R
Citation: Dc. Perlman et al., SUSCEPTIBILITY TO LEVOFLOXACIN OF MYCOBACTERIUM-TUBERCULOSIS ISOLATESFROM PATIENTS WITH HIV-RELATED TUBERCULOSIS AND CHARACTERIZATION OF ASTRAIN WITH LEVOFLOXACIN MONORESISTANCE, AIDS, 11(12), 1997, pp. 1473-1478
Authors:
PERLMAN DC
DESJARLAIS DC
SALOMON N
MASSON CL
Citation: Dc. Perlman et al., PREVENTING OPPORTUNISTIC INFECTIONS IN HIV-INFECTED INJECTION-DRUG USERS, JAMA, the journal of the American Medical Association, 278(21), 1997, pp. 1743-1743
Authors:
FRIEDMAN CR
QUINN GC
KREISWIRTH BN
PERLMAN DC
SALOMON N
SCHLUGER N
LUTFEY M
BERGER J
POLTORATSKAIA N
RILEY LW
Citation: Cr. Friedman et al., WIDESPREAD DISSEMINATION OF A DRUG-SUSCEPTIBLE STRAIN OF MYCOBACTERIUM-TUBERCULOSIS, The Journal of infectious diseases, 176(2), 1997, pp. 478-484
Citation: Dc. Perlman et N. Salomon, SELECTIVE MALABSORPTION AND THE ORIGIN OF MONO-RIFAMPIN-RESISTANT MYCOBACTERIUM-TUBERCULOSIS, American journal of respiratory and critical care medicine, 154(4), 1996, pp. 1213-1213
Authors:
GOMEZ TS
SALOMON N
LAYA L
EBER C
PERLMAN DC
MILDVAN D
Citation: Ts. Gomez et al., CLINICAL-FEATURES AND OUTCOMES OF CYTOMEGALOVIRUS PNEUMONIA IN HIV-INFECTED PERSONS, Clinical infectious diseases, 23(4), 1996, pp. 244-244
Citation: S. Goldstein et al., 2-STAGE TUBERCULIN SKIN TESTING IN AN HIV-INFECTED POPULATION - A PRELIMINARY-REPORT, The Mount Sinai journal of medicine, 61(4), 1994, pp. 337-340
Authors:
SALOMON N
PERLMAN DC
DEPALO VA
KOLOKATHIS A
WILETS I
Citation: N. Salomon et al., DRUG-RESISTANT TUBERCULOSIS - FACTORS ASSOCIATED WITH RISE IN RESISTANCE IN AN HIV-INFECTED URBAN-POPULATION, The Mount Sinai journal of medicine, 61(4), 1994, pp. 341-348